EcoR1 Capital, LLC has disclosed 51 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2023-12-31. The current portfolio value is calculated to be $3.85 Bil. The turnover rate is 17%.
In EcoR1 Capital, LLC's current portfolio as of 2023-12-31, the top 5 holdings are
Apellis Pharmaceuticals Inc (APLS), Mirati Therapeutics Inc (MRTX), Prothena Corp PLC (PRTA), Arvinas Inc (ARVN), Galapagos NV (GLPG), not including call and put options.
EcoR1 Capital, LLC did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for EcoR1 Capital, LLC, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for EcoR1 Capital, LLC, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for EcoR1 Capital, LLC.